English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Objectives: To determine the micro-RNA-145 expression in bladder cancer patients when compared with controls and clinicopathological parameters. Study design: A case control study. Place of Study: Samples were collected from Jinnah Postgraduate Medical Center Karachi and Civil Hospital Karachi. Duration of Study: January 2014 to December 2014. Materials and Methods: Total of 180 patients of bladder carcinoma were divided into three groups according to WHO/1998 classification system. PUNLMP in group-I, PUCLG in group-II, PUCHG in group-III were compared with 60 healthy controls in group-IV. Results: The results showed that miR-145 expression was decreased in patients with bladder cancer when compared with controls. Down regulation was more obvious in BC cases with increasing grade. A significant correlation was found between the expression of miR-145 with microscopic hematuria, cystoscopy and staging. Whereas no association was found with age, frequency, urgency, flank pain, gross hematuria, urine pH, and ultrasound. Conclusion: miR-145 is down regulated in BC patients with significant correlation with microscopic hematuria, cystoscopy and staging.

BLADDER CARCINOMA; MICRO-RNAS: EXPRESSION OF MIR-145 IN PATIENTS, AS A NEW DIAGNOSTIC APPROACH